Prognostic Value of Translocation 11;14 in Patients with Relapsed/Refractory Myeloma Receiving Anti-CD38 Therapy

Mohyuddin, G. R., Chakraborty, R., Calip, G., Ascha, M. S., Wang, X., Rubinstein, S., Tuchman, S. A., Costa, L. J., Haaland, B., Giri, S., Mian, H. S., Fonseca, R., & Sborov, D. W. (2022). Prognostic Value of Translocation 11;14 in Patients with Relapsed/Refractory Myeloma Receiving Anti-CD38 Therapy. Blood, 140(Supplement 1), 5223–5224. https://doi.org/10.1182/blood-2022-165541

Authors:

Ghulam Rehman Mohyuddin

Rajshekhar Chakraborty

Gregory S. Calip

Mustafa Ascha

Xiaoliang Wang

Samuel M. Rubinstein

Sascha A. Tuchman

Luciano J. Costa

Benjamin Haaland

Smith Giri

Hira Mian